Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest (OHCA)
Infection, Bacterial, Out-Of-Hospital Cardiac Arrest
About this trial
This is an interventional prevention trial for Infection, Bacterial
Eligibility Criteria
Inclusion Criteria: ● Adults aged >18 years, presenting to HGH ED after out-of-hospital cardiac arrest Patients with low likelihood of infection as per the definitions provided above Ability to obtain informed consent from the subjects or their next of kin/family member/legal surrogate in case of incapacitation due to sedation, mechanical ventilation, etc. In case the next of kin is not available, an independent physician who is not a part of the investigative team will complete and sign the checklist as per HMC Policy "RES 11026_Appendix 6.5". (see section 4.1.3 for details) A member of the investigative team and a witness will also sign this form before the potential subject is enrolled in the study. Exclusion Criteria: Patients who have clear evidence of infection, as defined by criteria for the study. Patients who have received antibiotics within the last 1 week prior to admission. Patients with malignancy, except those who have been cured or in complete remission. Females with known pregnancy. Known immunocompromised states (including HIV/AIDS, transplant recipients on immunosuppressant drugs, long-term [> 3 weeks of prednisone >5mg/day equivalent] steroid therapy). Patients on immunologic disease modifying agents (commonly known as "biologics") Patients considered "brain-dead" or "vegetative state" Patients transferred from another hospital, long term care facility or institution Neutropenia (total WBC <1,500/mm3 or absolute neutrophil count of <1,000/mm3)
Sites / Locations
- Hamad Medical Corporation
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Subject with antibiotics treatment
Subjects with no antibiotics treatment
Individuals with low risk of infection after OHCA will be randomized to either 1) early antibiotics, or 2) no antibiotics. Experimental arm received antibiotics as per local hospital clinical care pathways and physician choice.
Individuals with low risk of infection after OHCA will be randomized to either 1) early antibiotics, or 2) no antibiotics. Active comparator arm will receive no antibiotics,